SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Fair Play in Sport Act of 2002''.

SEC. 2. FINDINGS.

    The Congress finds that--
            (1) the National Commission on Sports and Substance Abuse, 
        sponsored by the National Center on Addiction and Substance 
        Abuse at Columbia University, found that most parties involved 
        in Olympic sports agree that doping (the use of banned 
        performance-enhancing substances) is a serious problem for the 
        Olympics and must be eliminated to preserve the integrity of 
        the competition;
            (2) the use of performance-enhancing substances in sports 
        threatens the health of our athletes, the integrity and meaning 
        of sport, and the health and ethical values of our children;
            (3) there is currently no set of long-term comprehensive 
        studies on the effects of performance-enhancing substances;
            (4) according to the Commission referred to in paragraph 
        (1), some problems which must be solved to enable a fair and 
        effective drug testing program include developing highly 
        accurate tests for performance-enhancing substances in the body 
        and establishing and accrediting testing laboratories around 
        the world;
            (5) the United States Government has recognized the United 
        States Anti-Doping Agency as the official anti-doping agency 
        for Olympic, Pan American, and Paralympic sport in the United 
        States, and provides significant financial support to such 
        Agency; and
            (6) the National Institute of Standards and Technology is 
        the Federal Government's premier laboratory for the development 
        of standards and testing methodology as well as for developing 
        rigorous testing laboratory accreditation procedures.

SEC. 3. RESEARCH FOR TESTING OF PERFORMANCE-ENHANCING SUBSTANCES.

    The National Institute of Standards and Technology, in consultation 
and cooperation with the United States Anti-Doping Agency, shall 
establish a research program to develop and improve the reliability, 
validity, and cost-effectiveness of testing for performance-enhancing 
substances the use of which is prohibited in the Olympic Games. Such 
research program shall--
            (1) pay particular attention to the development and 
        improvement of tests for the use of steroids, human growth 
        hormone, and insulin-like growth factor;
            (2) establish methods of ensuring that the ability to test 
        for the use of newly banned performance-enhancing substances is 
        maintained; and
            (3) develop standard reference materials to ensure the 
        accuracy of measurements.
Development of the agenda for the research program established under 
this section should be on the basis of the best available technology, 
regardless of the type of sample specimen used. All research projects 
should be evaluated on a peer-reviewed basis.

SEC. 4. ACCREDITATION PROCEDURES FOR TESTING LABORATORIES.

    The National Institute of Standards and Technology shall provide 
review and assessment assistance to the United States Anti-Doping 
Agency with respect to the laboratory accreditation process and testing 
procedures delineated in the International Olympic Committee's Olympic 
Movement Anti-Doping Code. Such assistance shall include--
            (1) procedures for accreditation of laboratories;
            (2) sampling procedures in doping controls; and
            (3) laboratory analysis procedures.
The National Institute of Standards and Technology shall limit its 
assistance under this section to areas where it has demonstrated 
technical competence.

SEC. 5. RESEARCH ON LONG-TERM CONSEQUENCES OF USE OF PERFORMANCE-
              ENHANCING SUBSTANCES.

    The National Institute of Standards and Technology, in consultation 
and cooperation with the United States Anti-Doping Agency, shall 
establish a research program to determine the long-term consequences of 
use of performance-enhancing substances. Development of the research 
agenda should place the highest priority on the most potentially 
harmful and the most widely used performance-enhancing substances. 
Priorities for research shall include--
            (1) the health effects of consumption of performance-
        enhancing substances; and
            (2) the efficacy and long-term effects of the use of 
        steroids, including precursor substances.
Population studies under this section should not be limited to elite 
athletes but should include adolescent athletes as well.

SEC. 6. AUTHORIZATION OF APPROPRIATIONS.

    There are authorized to be appropriated to the National Institute 
of Standards and Technology--
            (1) for carrying out sections 3 and 4, $5,000,000 for each 
        of the fiscal years 2003 through 2007; and
            (2) for carrying out section 5, $2,000,000 for each of the 
        fiscal years 2003 through 2007.
Fair Play in Sport Act of 2002 - Directs the National Institute of Standards and Technology (NIST), in consultation and cooperation with the United States Anti-Doping Agency, to: (1) establish a research program to develop and improve the reliability, validity, and cost-effectiveness of testing for performance-enhancing substances the use of which is prohibited in the Olympic Games; and (2) establish a research program to determine the long-term consequences of the use of such substances. Requires NIST to provide review and assessment assistance to the Agency with respect to the laboratory accreditation process and testing procedures delineated in the International Olympic Committee's Olympic Movement Anti-Doping Code.
To authorize the National Institute of Standards and Technology to assist in the development of reliable and valid tests for banned performance-enhancing substances and to establish a research program on the long-term consequences of the use of such performance-enhancing substances.